Drugs / Colon GVAX
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00656123 | Mar 2008 → Aug 2011 | colorectal cancer, metastatic malignant neoplasm | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Colon GVAX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00656123 ↗ |
| Modality | Vaccine | “A novel colorectal cancer vaccine composed of irradiated, allogeneic human colon cancer cells and GM-CSF-producing bystander cells was developed” PMID 24943235 ↗ Jun 2014 |
| Route | Other | “cells administered in up to 15 intradermal injections” NCT00656123 ↗ |